The University of Texas MD Anderson Cancer Center: Interdisciplinary Cancer Care Custom Case Solution & Analysis

Evidence Brief: MD Anderson Cancer Center

1. Financial Metrics

2. Operational Facts

• Structure: Historically organized into 54 academic departments based on medical specialties such as surgery, radiation, and diagnostic imaging.
• Patient Volume: Over 70,000 individual patients treated annually, with 20,000 new patients per year.
• Headcount: 15,000 employees, including 1,000 faculty members and 2,500 nurses.
• Geography: Central campus in Houston, Texas, with multiple satellite locations in the surrounding region.
• Process: Traditional patient journeys required multiple visits across disparate buildings for a single diagnosis, often spanning several days.

3. Stakeholder Positions

• Dr. John Mendelsohn (President): Advocates for a transition to Integrated Care Centers (ICCs) to improve patient experience and clinical outcomes.
• Department Chairs: Control budgets, space, and faculty recruitment. Many view the ICC model as a threat to their traditional authority and academic focus.
• Faculty Members: Concerned that interdisciplinary structures will dilute specialized research time and complicate the tenure process.
• Patients: Express frustration with fragmented care and the physical distance between specialist appointments.

4. Information Gaps

• Specific profitability margins for individual cancer types under the old versus new model.
• Detailed cost-benefit analysis of the administrative overhead required to manage a matrix organization.
• Quantitative data on faculty retention rates during the initial pilot phase of the ICC transition.

Strategic Analysis

1. Core Strategic Question

• How can MD Anderson transition from a specialty-based academic structure to a patient-centered interdisciplinary model without compromising research excellence or alienating the power-holding department chairs?

2. Structural Analysis

The traditional Value Chain at MD Anderson is fragmented. While clinical expertise is high, the delivery of that expertise is inefficient. Using the Value-Based Healthcare framework, the institution must shift from volume of services to the quality of patient outcomes per dollar spent. The current departmental silo structure creates high friction costs and reduces the speed of multi-modality treatment planning.

3. Strategic Options

• Option 1: Full Matrix Integration. Maintain academic departments for research and tenure while shifting all clinical operations, budgets, and staff reporting lines to organ-site ICCs.
  • Rationale: Aligns financial incentives with patient outcomes.
  • Trade-offs: High risk of administrative bloat and conflict between clinical directors and department chairs.
• Option 2: The Pilot and Expand Model. Launch ICCs for high-volume, high-complexity cancers (Breast, Lung, Prostate) while leaving rare cancers in traditional departments.
  • Rationale: Minimizes institutional shock and allows for process refinement.
  • Trade-offs: Creates a two-tier system and delays the necessary cultural shift across the entire organization.
• Option 3: Virtual Integration via Technology. Maintain physical silos but use advanced coordination software and multidisciplinary tumor boards to manage care.
  • Rationale: Low disruption to existing power structures and physical assets.
  • Trade-offs: Fails to address the fundamental patient complaint regarding physical travel and fragmented communication.

4. Preliminary Recommendation

MD Anderson should pursue Option 1: Full Matrix Integration. The competitive landscape in oncology is shifting toward specialized centers. To maintain its market position, the center must prioritize the patient journey. Success requires a fundamental shift in how revenue is recognized—moving it from the department of the physician to the ICC where the care is delivered.

Implementation Roadmap

1. Critical Path

• Month 1-3: Financial Realignment. Develop a shadow budget system that tracks revenue and expenses by ICC. This must be completed before physical relocation to ensure financial transparency.
• Month 4-6: Space and Asset Reallocation. Move specialists into shared clinical pods. Surgeons, oncologists, and radiation therapists must share the same physical work environment to facilitate informal consultation.
• Month 7-12: Incentive Redesign. Reform the faculty evaluation process. Promotion and bonuses must be tied to ICC performance metrics, including patient satisfaction and interdisciplinary research output, rather than just departmental service.

2. Key Constraints

• Departmental Authority: The power of department chairs over faculty careers is the primary obstacle. Implementation will fail unless the President empowers ICC Directors with equal weight in tenure and promotion decisions.
• Physical Infrastructure: Current buildings were designed for specialty silos. Reconfiguring these spaces requires significant capital and creates operational downtime.

3. Risk-Adjusted Implementation Strategy

To mitigate the risk of faculty exodus, the transition must include a Research Protection Clause. This ensures that even as clinical duties move to ICCs, faculty members retain protected time for specialized lab work. A phased rollout by building, rather than by cancer type, will reduce the confusion of managing two different operational models simultaneously in the same facility.

Executive Review and BLUF

1. BLUF

MD Anderson must immediately transition to an Integrated Care Center (ICC) model to protect its status as a premier cancer institution. The current departmental structure serves academic interests at the expense of patient outcomes and operational efficiency. The recommendation is to move to a matrix organization where clinical revenue and operational control reside within organ-site centers, while academic departments remain solely for research and education. This shift is not merely an operational adjustment but a necessary evolution to meet the rising demand for coordinated, value-based oncology care. Execution must focus on breaking the financial and promotional monopoly of department chairs.

2. Dangerous Assumption

The analysis assumes that clinical faculty will prioritize patient-centered efficiency over the traditional academic prestige and autonomy associated with their specific medical departments. If faculty perceive this shift as a demotion to clinical service providers, the institution faces a catastrophic loss of its top research talent.

3. Unaddressed Risks

• Payer Resistance: Insurance providers may not be prepared to reimburse under a bundled ICC model, leading to significant billing delays and revenue cycles extending beyond 120 days.
• Administrative Gridlock: The matrix structure requires dual reporting lines. Without a clear tie-breaker mechanism, decision-making regarding staff hiring and equipment purchase will slow significantly.

4. Unconsidered Alternative

The team did not consider a Complete Decentralization model. In this scenario, MD Anderson would dissolve traditional departments entirely, creating independent organ-site institutes (e.g., The MD Anderson Breast Cancer Institute). This would eliminate matrix conflict but would risk losing the benefits of cross-pollination in basic science research that occurs within medical specialties.

5. MECE Verdict

APPROVED FOR LEADERSHIP REVIEW